aluates Reports

$ 0.0

Automative

Global Direct Oral Anticoagulant Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-18O7527

Global Direct Oral Anticoagulant Market Insights Forecast to 2028

BUY CHAPTERS

Global Direct Oral Anticoagulant Market Research Report 2025

Code: QYRE-Auto-18O7527

Report

July 2025

Pages:83

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bristol-Meyers Squibb Co

Pfizer Inc

Boehringer Ingelheim Pharmaceuticals, Inc

Janssen Pharmaceuticals, Inc.

Bayer

Teva Pharmaceutical Industries Ltd

Pab Organics Private Limited

Daiichi Sankyo Company Limited

Direct Oral Anticoagulant Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Direct Oral Anticoagulant Market

The global market for Direct Oral Anticoagulant was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.

The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Direct Oral Anticoagulant, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Direct Oral Anticoagulant.

The Direct Oral Anticoagulant market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Direct Oral Anticoagulant market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Direct Oral Anticoagulant manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Direct Oral Anticoagulant Market Report

Report Metric	Details
Report Name	Direct Oral Anticoagulant Market
Accounted market size in year	US$ 603 billion
CAGR	5%
Base Year	year
Segment by Type	Apixaban Dabigatran Rivaroxaban Edoxaban
Segment by Application	Hospitals Pharmacies Drug Stores Online Pharmacies
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Bristol-Meyers Squibb Co, Pfizer Inc., Boehringer Ingelheim Pharmaceuticals, Inc, Janssen Pharmaceuticals, Inc., Bayer AG, Teva Pharmaceutical Industries Ltd, Pab Organics Private Limited, Daiichi Sankyo Company, Limited
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Direct Oral Anticoagulant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Direct Oral Anticoagulant in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Direct Oral Anticoagulant Market report?

Ans: The main players in the Direct Oral Anticoagulant Market are Bristol-Meyers Squibb Co, Pfizer Inc., Boehringer Ingelheim Pharmaceuticals, Inc, Janssen Pharmaceuticals, Inc., Bayer AG, Teva Pharmaceutical Industries Ltd, Pab Organics Private Limited, Daiichi Sankyo Company, Limited

What are the Application segmentation covered in the Direct Oral Anticoagulant Market report?

Ans: The Applications covered in the Direct Oral Anticoagulant Market report are Hospitals Pharmacies, Drug Stores, Online Pharmacies

What are the Type segmentation covered in the Direct Oral Anticoagulant Market report?

Ans: The Types covered in the Direct Oral Anticoagulant Market report are Apixaban, Dabigatran, Rivaroxaban, Edoxaban

Recommended Reports

Coagulation Devices

Anticoagulant Drugs

Hemostasis Solutions

1 Direct Oral Anticoagulant Market Overview

1.1 Product Definition

1.2 Direct Oral Anticoagulant by Type

1.2.1 Global Direct Oral Anticoagulant Market Value Comparison by Type (2024 VS 2031)

1.2.2 Apixaban

1.2.3 Dabigatran

1.2.4 Rivaroxaban

1.2.5 Edoxaban

1.3 Direct Oral Anticoagulant by Application

1.3.1 Global Direct Oral Anticoagulant Market Value by Application (2024 VS 2031)

1.3.2 Hospitals Pharmacies

1.3.3 Drug Stores

1.3.4 Online Pharmacies

1.4 Global Direct Oral Anticoagulant Market Size Estimates and Forecasts

1.4.1 Global Direct Oral Anticoagulant Revenue 2020-2031

1.4.2 Global Direct Oral Anticoagulant Sales 2020-2031

1.4.3 Global Direct Oral Anticoagulant Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Direct Oral Anticoagulant Market Competition by Manufacturers

2.1 Global Direct Oral Anticoagulant Sales Market Share by Manufacturers (2020-2025)

2.2 Global Direct Oral Anticoagulant Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Direct Oral Anticoagulant Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Direct Oral Anticoagulant, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Direct Oral Anticoagulant, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Direct Oral Anticoagulant, Product Type & Application

2.7 Global Key Manufacturers of Direct Oral Anticoagulant, Date of Enter into This Industry

2.8 Global Direct Oral Anticoagulant Market Competitive Situation and Trends

2.8.1 Global Direct Oral Anticoagulant Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Direct Oral Anticoagulant Players Market Share by Revenue

2.8.3 Global Direct Oral Anticoagulant Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Direct Oral Anticoagulant Market Scenario by Region

3.1 Global Direct Oral Anticoagulant Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Direct Oral Anticoagulant Sales by Region: 2020-2031

3.2.1 Global Direct Oral Anticoagulant Sales by Region: 2020-2025

3.2.2 Global Direct Oral Anticoagulant Sales by Region: 2026-2031

3.3 Global Direct Oral Anticoagulant Revenue by Region: 2020-2031

3.3.1 Global Direct Oral Anticoagulant Revenue by Region: 2020-2025

3.3.2 Global Direct Oral Anticoagulant Revenue by Region: 2026-2031

3.4 North America Direct Oral Anticoagulant Market Facts & Figures by Country

3.4.1 North America Direct Oral Anticoagulant Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Direct Oral Anticoagulant Sales by Country (2020-2031)

3.4.3 North America Direct Oral Anticoagulant Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Direct Oral Anticoagulant Market Facts & Figures by Country

3.5.1 Europe Direct Oral Anticoagulant Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Direct Oral Anticoagulant Sales by Country (2020-2031)

3.5.3 Europe Direct Oral Anticoagulant Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Direct Oral Anticoagulant Market Facts & Figures by Region

3.6.1 Asia Pacific Direct Oral Anticoagulant Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Direct Oral Anticoagulant Sales by Region (2020-2031)

3.6.3 Asia Pacific Direct Oral Anticoagulant Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Direct Oral Anticoagulant Market Facts & Figures by Country

3.7.1 Latin America Direct Oral Anticoagulant Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Direct Oral Anticoagulant Sales by Country (2020-2031)

3.7.3 Latin America Direct Oral Anticoagulant Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Direct Oral Anticoagulant Market Facts & Figures by Country

3.8.1 Middle East and Africa Direct Oral Anticoagulant Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Direct Oral Anticoagulant Sales by Country (2020-2031)

3.8.3 Middle East and Africa Direct Oral Anticoagulant Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Direct Oral Anticoagulant Sales by Type (2020-2031)

4.1.1 Global Direct Oral Anticoagulant Sales by Type (2020-2025)

4.1.2 Global Direct Oral Anticoagulant Sales by Type (2026-2031)

4.1.3 Global Direct Oral Anticoagulant Sales Market Share by Type (2020-2031)

4.2 Global Direct Oral Anticoagulant Revenue by Type (2020-2031)

4.2.1 Global Direct Oral Anticoagulant Revenue by Type (2020-2025)

4.2.2 Global Direct Oral Anticoagulant Revenue by Type (2026-2031)

4.2.3 Global Direct Oral Anticoagulant Revenue Market Share by Type (2020-2031)

4.3 Global Direct Oral Anticoagulant Price by Type (2020-2031)

5 Segment by Application

5.1 Global Direct Oral Anticoagulant Sales by Application (2020-2031)

5.1.1 Global Direct Oral Anticoagulant Sales by Application (2020-2025)

5.1.2 Global Direct Oral Anticoagulant Sales by Application (2026-2031)

5.1.3 Global Direct Oral Anticoagulant Sales Market Share by Application (2020-2031)

5.2 Global Direct Oral Anticoagulant Revenue by Application (2020-2031)

5.2.1 Global Direct Oral Anticoagulant Revenue by Application (2020-2025)

5.2.2 Global Direct Oral Anticoagulant Revenue by Application (2026-2031)

5.2.3 Global Direct Oral Anticoagulant Revenue Market Share by Application (2020-2031)

5.3 Global Direct Oral Anticoagulant Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Bristol-Meyers Squibb Co

6.1.1 Bristol-Meyers Squibb Co Company Information

6.1.2 Bristol-Meyers Squibb Co Description and Business Overview

6.1.3 Bristol-Meyers Squibb Co Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Bristol-Meyers Squibb Co Direct Oral Anticoagulant Product Portfolio

6.1.5 Bristol-Meyers Squibb Co Recent Developments/Updates

6.2 Pfizer Inc.

6.2.1 Pfizer Inc. Company Information

6.2.2 Pfizer Inc. Description and Business Overview

6.2.3 Pfizer Inc. Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Pfizer Inc. Direct Oral Anticoagulant Product Portfolio

6.2.5 Pfizer Inc. Recent Developments/Updates

6.3 Boehringer Ingelheim Pharmaceuticals, Inc

6.3.1 Boehringer Ingelheim Pharmaceuticals, Inc Company Information

6.3.2 Boehringer Ingelheim Pharmaceuticals, Inc Description and Business Overview

6.3.3 Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Product Portfolio

6.3.5 Boehringer Ingelheim Pharmaceuticals, Inc Recent Developments/Updates

6.4 Janssen Pharmaceuticals, Inc.

6.4.1 Janssen Pharmaceuticals, Inc. Company Information

6.4.2 Janssen Pharmaceuticals, Inc. Description and Business Overview

6.4.3 Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Product Portfolio

6.4.5 Janssen Pharmaceuticals, Inc. Recent Developments/Updates

6.5 Bayer AG

6.5.1 Bayer AG Company Information

6.5.2 Bayer AG Description and Business Overview

6.5.3 Bayer AG Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Bayer AG Direct Oral Anticoagulant Product Portfolio

6.5.5 Bayer AG Recent Developments/Updates

6.6 Teva Pharmaceutical Industries Ltd

6.6.1 Teva Pharmaceutical Industries Ltd Company Information

6.6.2 Teva Pharmaceutical Industries Ltd Description and Business Overview

6.6.3 Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Product Portfolio

6.6.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates

6.7 Pab Organics Private Limited

6.7.1 Pab Organics Private Limited Company Information

6.7.2 Pab Organics Private Limited Description and Business Overview

6.7.3 Pab Organics Private Limited Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Pab Organics Private Limited Direct Oral Anticoagulant Product Portfolio

6.7.5 Pab Organics Private Limited Recent Developments/Updates

6.8 Daiichi Sankyo Company, Limited

6.8.1 Daiichi Sankyo Company, Limited Company Information

6.8.2 Daiichi Sankyo Company, Limited Description and Business Overview

6.8.3 Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Product Portfolio

6.8.5 Daiichi Sankyo Company, Limited Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Direct Oral Anticoagulant Industry Chain Analysis

7.2 Direct Oral Anticoagulant Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Direct Oral Anticoagulant Production Mode & Process Analysis

7.4 Direct Oral Anticoagulant Sales and Marketing

7.4.1 Direct Oral Anticoagulant Sales Channels

7.4.2 Direct Oral Anticoagulant Distributors

7.5 Direct Oral Anticoagulant Customer Analysis

8 Direct Oral Anticoagulant Market Dynamics

8.1 Direct Oral Anticoagulant Industry Trends

8.2 Direct Oral Anticoagulant Market Drivers

8.3 Direct Oral Anticoagulant Market Challenges

8.4 Direct Oral Anticoagulant Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Bristol-Meyers Squibb Co

Pfizer Inc

Boehringer Ingelheim Pharmaceuticals, Inc

Janssen Pharmaceuticals, Inc.

Bayer

Teva Pharmaceutical Industries Ltd

Pab Organics Private Limited

Daiichi Sankyo Company Limited

List of Tables

Table 1. Global Direct Oral Anticoagulant Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Direct Oral Anticoagulant Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Direct Oral Anticoagulant Market Competitive Situation by Manufacturers in 2024

Table 4. Global Direct Oral Anticoagulant Sales (MT) of Key Manufacturers (2020-2025)

Table 5. Global Direct Oral Anticoagulant Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Direct Oral Anticoagulant Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Direct Oral Anticoagulant Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Direct Oral Anticoagulant Average Price (USD/Kg) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Direct Oral Anticoagulant, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Direct Oral Anticoagulant, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Direct Oral Anticoagulant, Product Type & Application

Table 12. Global Key Manufacturers of Direct Oral Anticoagulant, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Direct Oral Anticoagulant by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Direct Oral Anticoagulant as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Direct Oral Anticoagulant Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Direct Oral Anticoagulant Sales by Region (2020-2025) & (MT)

Table 18. Global Direct Oral Anticoagulant Sales Market Share by Region (2020-2025)

Table 19. Global Direct Oral Anticoagulant Sales by Region (2026-2031) & (MT)

Table 20. Global Direct Oral Anticoagulant Sales Market Share by Region (2026-2031)

Table 21. Global Direct Oral Anticoagulant Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Direct Oral Anticoagulant Revenue Market Share by Region (2020-2025)

Table 23. Global Direct Oral Anticoagulant Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Direct Oral Anticoagulant Revenue Market Share by Region (2026-2031)

Table 25. North America Direct Oral Anticoagulant Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Direct Oral Anticoagulant Sales by Country (2020-2025) & (MT)

Table 27. North America Direct Oral Anticoagulant Sales by Country (2026-2031) & (MT)

Table 28. North America Direct Oral Anticoagulant Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Direct Oral Anticoagulant Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Direct Oral Anticoagulant Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Direct Oral Anticoagulant Sales by Country (2020-2025) & (MT)

Table 32. Europe Direct Oral Anticoagulant Sales by Country (2026-2031) & (MT)

Table 33. Europe Direct Oral Anticoagulant Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Direct Oral Anticoagulant Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Direct Oral Anticoagulant Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Direct Oral Anticoagulant Sales by Region (2020-2025) & (MT)

Table 37. Asia Pacific Direct Oral Anticoagulant Sales by Region (2026-2031) & (MT)

Table 38. Asia Pacific Direct Oral Anticoagulant Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Direct Oral Anticoagulant Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Direct Oral Anticoagulant Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Direct Oral Anticoagulant Sales by Country (2020-2025) & (MT)

Table 42. Latin America Direct Oral Anticoagulant Sales by Country (2026-2031) & (MT)

Table 43. Latin America Direct Oral Anticoagulant Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Direct Oral Anticoagulant Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Direct Oral Anticoagulant Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Direct Oral Anticoagulant Sales by Country (2020-2025) & (MT)

Table 47. Middle East and Africa Direct Oral Anticoagulant Sales by Country (2026-2031) & (MT)

Table 48. Middle East and Africa Direct Oral Anticoagulant Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Direct Oral Anticoagulant Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Direct Oral Anticoagulant Sales (MT) by Type (2020-2025)

Table 51. Global Direct Oral Anticoagulant Sales (MT) by Type (2026-2031)

Table 52. Global Direct Oral Anticoagulant Sales Market Share by Type (2020-2025)

Table 53. Global Direct Oral Anticoagulant Sales Market Share by Type (2026-2031)

Table 54. Global Direct Oral Anticoagulant Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Direct Oral Anticoagulant Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Direct Oral Anticoagulant Revenue Market Share by Type (2020-2025)

Table 57. Global Direct Oral Anticoagulant Revenue Market Share by Type (2026-2031)

Table 58. Global Direct Oral Anticoagulant Price (USD/Kg) by Type (2020-2025)

Table 59. Global Direct Oral Anticoagulant Price (USD/Kg) by Type (2026-2031)

Table 60. Global Direct Oral Anticoagulant Sales (MT) by Application (2020-2025)

Table 61. Global Direct Oral Anticoagulant Sales (MT) by Application (2026-2031)

Table 62. Global Direct Oral Anticoagulant Sales Market Share by Application (2020-2025)

Table 63. Global Direct Oral Anticoagulant Sales Market Share by Application (2026-2031)

Table 64. Global Direct Oral Anticoagulant Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Direct Oral Anticoagulant Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Direct Oral Anticoagulant Revenue Market Share by Application (2020-2025)

Table 67. Global Direct Oral Anticoagulant Revenue Market Share by Application (2026-2031)

Table 68. Global Direct Oral Anticoagulant Price (USD/Kg) by Application (2020-2025)

Table 69. Global Direct Oral Anticoagulant Price (USD/Kg) by Application (2026-2031)

Table 70. Bristol-Meyers Squibb Co Company Information

Table 71. Bristol-Meyers Squibb Co Description and Business Overview

Table 72. Bristol-Meyers Squibb Co Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 73. Bristol-Meyers Squibb Co Direct Oral Anticoagulant Product

Table 74. Bristol-Meyers Squibb Co Recent Developments/Updates

Table 75. Pfizer Inc. Company Information

Table 76. Pfizer Inc. Description and Business Overview

Table 77. Pfizer Inc. Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 78. Pfizer Inc. Direct Oral Anticoagulant Product

Table 79. Pfizer Inc. Recent Developments/Updates

Table 80. Boehringer Ingelheim Pharmaceuticals, Inc Company Information

Table 81. Boehringer Ingelheim Pharmaceuticals, Inc Description and Business Overview

Table 82. Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 83. Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Product

Table 84. Boehringer Ingelheim Pharmaceuticals, Inc Recent Developments/Updates

Table 85. Janssen Pharmaceuticals, Inc. Company Information

Table 86. Janssen Pharmaceuticals, Inc. Description and Business Overview

Table 87. Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 88. Janssen Pharmaceuticals, Inc. Direct Oral Anticoagulant Product

Table 89. Janssen Pharmaceuticals, Inc. Recent Developments/Updates

Table 90. Bayer AG Company Information

Table 91. Bayer AG Description and Business Overview

Table 92. Bayer AG Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 93. Bayer AG Direct Oral Anticoagulant Product

Table 94. Bayer AG Recent Developments/Updates

Table 95. Teva Pharmaceutical Industries Ltd Company Information

Table 96. Teva Pharmaceutical Industries Ltd Description and Business Overview

Table 97. Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 98. Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Product

Table 99. Teva Pharmaceutical Industries Ltd Recent Developments/Updates

Table 100. Pab Organics Private Limited Company Information

Table 101. Pab Organics Private Limited Description and Business Overview

Table 102. Pab Organics Private Limited Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 103. Pab Organics Private Limited Direct Oral Anticoagulant Product

Table 104. Pab Organics Private Limited Recent Developments/Updates

Table 105. Daiichi Sankyo Company, Limited Company Information

Table 106. Daiichi Sankyo Company, Limited Description and Business Overview

Table 107. Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 108. Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Product

Table 109. Daiichi Sankyo Company, Limited Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Direct Oral Anticoagulant Distributors List

Table 113. Direct Oral Anticoagulant Customers List

Table 114. Direct Oral Anticoagulant Market Trends

Table 115. Direct Oral Anticoagulant Market Drivers

Table 116. Direct Oral Anticoagulant Market Challenges

Table 117. Direct Oral Anticoagulant Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Product Picture of Direct Oral Anticoagulant

Figure 2. Global Direct Oral Anticoagulant Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Direct Oral Anticoagulant Market Share by Type: 2024 & 2031

Figure 4. Apixaban Product Picture

Figure 5. Dabigatran Product Picture

Figure 6. Rivaroxaban Product Picture

Figure 7. Edoxaban Product Picture

Figure 8. Global Direct Oral Anticoagulant Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Direct Oral Anticoagulant Market Share by Application: 2024 & 2031

Figure 10. Hospitals Pharmacies

Figure 11. Drug Stores

Figure 12. Online Pharmacies

Figure 13. Global Direct Oral Anticoagulant Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Direct Oral Anticoagulant Market Size (2020-2031) & (US$ Million)

Figure 15. Global Direct Oral Anticoagulant Sales (2020-2031) & (MT)

Figure 16. Global Direct Oral Anticoagulant Average Price (USD/Kg) & (2020-2031)

Figure 17. Direct Oral Anticoagulant Report Years Considered

Figure 18. Direct Oral Anticoagulant Sales Share by Manufacturers in 2024

Figure 19. Global Direct Oral Anticoagulant Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Direct Oral Anticoagulant Players: Market Share by Revenue in Direct Oral Anticoagulant in 2024

Figure 21. Direct Oral Anticoagulant Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Direct Oral Anticoagulant Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Direct Oral Anticoagulant Sales Market Share by Country (2020-2031)

Figure 24. North America Direct Oral Anticoagulant Revenue Market Share by Country (2020-2031)

Figure 25. U.S. Direct Oral Anticoagulant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Direct Oral Anticoagulant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Direct Oral Anticoagulant Sales Market Share by Country (2020-2031)

Figure 28. Europe Direct Oral Anticoagulant Revenue Market Share by Country (2020-2031)

Figure 29. Germany Direct Oral Anticoagulant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Direct Oral Anticoagulant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Direct Oral Anticoagulant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Direct Oral Anticoagulant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Direct Oral Anticoagulant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Direct Oral Anticoagulant Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Direct Oral Anticoagulant Revenue Market Share by Region (2020-2031)

Figure 36. China Direct Oral Anticoagulant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Direct Oral Anticoagulant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Direct Oral Anticoagulant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Direct Oral Anticoagulant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Direct Oral Anticoagulant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Taiwan Direct Oral Anticoagulant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Indonesia Direct Oral Anticoagulant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Thailand Direct Oral Anticoagulant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Malaysia Direct Oral Anticoagulant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Philippines Direct Oral Anticoagulant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Latin America Direct Oral Anticoagulant Sales Market Share by Country (2020-2031)

Figure 47. Latin America Direct Oral Anticoagulant Revenue Market Share by Country (2020-2031)

Figure 48. Mexico Direct Oral Anticoagulant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Brazil Direct Oral Anticoagulant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Argentina Direct Oral Anticoagulant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Middle East and Africa Direct Oral Anticoagulant Sales Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Direct Oral Anticoagulant Revenue Market Share by Country (2020-2031)

Figure 53. Turkey Direct Oral Anticoagulant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Direct Oral Anticoagulant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. U.A.E Direct Oral Anticoagulant Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Global Sales Market Share of Direct Oral Anticoagulant by Type (2020-2031)

Figure 57. Global Revenue Market Share of Direct Oral Anticoagulant by Type (2020-2031)

Figure 58. Global Direct Oral Anticoagulant Price (USD/Kg) by Type (2020-2031)

Figure 59. Global Sales Market Share of Direct Oral Anticoagulant by Application (2020-2031)

Figure 60. Global Revenue Market Share of Direct Oral Anticoagulant by Application (2020-2031)

Figure 61. Global Direct Oral Anticoagulant Price (USD/Kg) by Application (2020-2031)

Figure 62. Direct Oral Anticoagulant Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Anticoagulants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Heparin Anticoagulant Market Insights Forecast to 2028

Global Novel Oral Anticoagulants Drugs Market Insights Forecast to 2030

Global Direct Oral Anticoagulants DOACs Market Research Report 2024

Global Anticoagulant Drugs Market Insights Forecast to 2030

Global Oral Anticoagulant Reversal Drug Market Research Report 2025

Global Oral Factor Xa Inhibitors Market Research Report 2024

Global Anticoagulant Treatment Market Insights Forecast to 2030

Global Anticoagulant Medications Market Research Report 2024

Global Anticoagulant Medicines Market Research Report 2025

Global Intravenous Anticoagulants Market Research Report 2024

Global Rivaroxaban Drugs Market Research Report 2024

Global Anticoagulant Medicine Market Research Report 2025

Global Oral Anti Diabetic Drug Market Insights Forecast to 2030

Global Warfarin Sodium Tablets Market Research Report 2024

Global Injectable Blood Thinners Market Research Report 2025

Global Anticoagulant Injections Market Research Report 2025

Global Edoxaban API Market Research Report 2024

Global Heparin Anticoagulation Tube Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions